<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Clin Res Pediatr Endocrinol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Clin Res Pediatr Endocrinol</journal-id>
      <journal-id journal-id-type="publisher-id">JCRPE</journal-id>
      <journal-title-group>
        <journal-title>Journal of Clinical Research in Pediatric Endocrinology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1308-5727</issn>
      <issn pub-type="epub">1308-5735</issn>
      <publisher>
        <publisher-name>Galenos Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23149434</article-id>
      <article-id pub-id-type="pmc">3537291</article-id>
      <article-id pub-id-type="doi">10.4274/Jcrpe.787</article-id>
      <article-id pub-id-type="pii">227</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hypochondroplasia in a Child with 1620C&gt;G (Asn540Lys) Mutation in FGFR3</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Korkmaz</surname>
            <given-names>H&#xFC;seyin An&#x131;l</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hazan</surname>
            <given-names>Filiz</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dizdarer</surname>
            <given-names>Ceyhun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>T&#xFC;k&#xFC;n</surname>
            <given-names>Ajlan</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>
Dr. Beh&#xE7;et Uz Children Disease and Surgery Training and Research Hospital, Department of Pediatric Endocrinology, &#x130;zmir, Turkey
</aff>
      <aff id="A2"><label>2</label>
Dr. Beh&#xE7;et Uz Children Disease and Surgery Training and Research Hospital, Department of Genetics, &#x130;zmir, Turkey
</aff>
      <aff id="A3"><label>3</label>
Ankara University Faculty of Medicine, Department of Medical Genetics, Ankara, Turkey
</aff>
      <author-notes>
        <corresp id="COR1">* Address for Correspondence: MD, Dr. Beh&#xE7;et Uz Children Disease and Surgery Training and Research Hospital, Department of Pediatric Endocrinology, &#x130;zmir, Turkey Phone: +90 232 489 56 56 E-mail: <email>drkorkmazanil@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <volume>4</volume>
      <issue>4</issue>
      <fpage>220</fpage>
      <lpage>222</lpage>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Journal of Clinical Research in Pediatric Endocrinology, Published by Galenos Publishing.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Hypochondroplasia (HCP) is an autosomal dominant skeletal dysplasia characterized by short extremities, short stature and lumbar lordosis, usually exhibiting a phenotype similar to but milder than achondroplasia (ACP). Fibroblast growth factor receptor 3 gene (FGFR3) mutations in the germline are well-known causes of skeletal syndromes. FGFR3 is a negative regulator of bone growth and all mutations in FGFR3 are gain-of-function mutations that lead to skeletal dysplasias. We report a child who presented with short stature, a relatively long trunk, short legs, short arm span, radiographic evidence of HCP and mild mental retardation. Genetic analysis revealed a heterozygous 1620C&gt;G (Asn540Lys) mutation in FGFR3. To our knowledge, ours is the first case report of HCP with a heterozygous 1620C&gt;G (Asn540Lys) mutation in Turkey.</p>
        <p><bold>Conflict of interest:</bold>None declared.</p>
      </abstract>
      <kwd-group>
        <kwd>Hypochondroplasia</kwd>
        <kwd>fibroblast growth factor receptor 3</kwd>
        <kwd>short stature</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Hypochondroplasia (HCP) and achondroplasia (ACP) are two common skeletal disorders caused by heterozygous mutations in the fibroblast growth factor receptor 3 gene (FGFR3) (<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>). FGFR3 is located on chromosome 4 (4p16.3) and is composed of 19 exons and 18 introns (3). All of the mutations are inherited in a dominant pattern. Two mutations (1620C&gt;A and 1620C&gt;G) account for50-70% of all cases with HCP (<xref ref-type="bibr" rid="ref4">4</xref>). Herein, we present a patient with HCP.</p>
    </sec>
    <sec>
      <title>CASE REPORTS</title>
      <p>A 4 8/12 years old female patient presented to our clinic with short stature. She was the second child of a 24-year-old mother and her 28-year-old husband. She was born full-term by normal vaginal delivery following an uncomplicated pregnancy. Her birth weight was 3050 g and her birth length was 46 cm.</p>
      <p>At presentation, the patient&#x2019;s anthropometric measurements revealed a height of 97 cm [-2.18 standard deviation score (SDS)] and a head circumference of 54 cm (+3.71 SDS); head circumference SDS-height SDS (DHc/Ht) SDS=+5.89. Physical examination showed skeletal disproportion with short limbs and a relatively long trunk [upper to lower segment ratio: 1.21 (&gt;2 SDS)], brachydactyly, metaphyseal flaring, limitation of elbow extension, short legs [sitting height/height ratio: 0.6 (&gt;2.5 SDS)] and a short arm span (10 cm shorter than her total height) (<xref ref-type="fig" rid="f1">Figure 1</xref>). Her mother&#x2019;s and father&#x2019;s height were 154 and 172 cm, respectively, and target height was calculated as 156.5 cm. The patient&#x2019;s developmental milestones were normal, but she had mild mental retardation. Neuropsychological evaluation (Bayley) revealed a developmental index of 60, a value below normal. She showed difficulties especially in language skills. Radiographic examination revealed characteristic features of HCP including a fibula longer than the tibia, square iliae and short femoral necks, a shortening of the pedicles of the vertebrae, with a narrowing of interpedicular distances. The large tubular bones were short and squat, with small epiphyses. The tubular hand bones were also slightly short. Muscle tone was normal, but motion range in many large and small joints was slightly increased. Bone age was 4 years. The karyotype was 46,XX.</p>
      <p>We isolated genomic DNA from blood lymphocytes of the patient by standard procedures. Four coding exons (<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref10">10</xref>, <xref ref-type="bibr" rid="ref13">13</xref>, and <xref ref-type="bibr" rid="ref15">15</xref>) of FGFR3 were amplified using methods described previously (<xref ref-type="bibr" rid="ref5">5</xref>). The polymerase chain reaction products were purified and sequenced on an ABI PRISM 3130 automated DNA sequencer (Applied Biosystems). A heterozygous 1620C&gt;G (Asn540Lys) mutation was detected in exon 13.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>HCP is an autosomal dominant skeletal disorder, and mutations in FGFR3 are present in most patients (<xref ref-type="bibr" rid="ref3">3</xref>). In patients with HCP, the skeletal features are less severe than in patients with ACP (<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>). Therefore, the diagnosis of HCP is often difficult, and some affected patients may be evaluated as idiopathic short stature. Our patient presented with short stature (&lt;-2 SDS) and she had a relatively long trunk, short legs and a short arm span. Her clinical and radiological features included macrocephaly, brachydactyly, metaphyseal flaring, limitation of elbow extension, shortening of the pedicles of the vertebrae, narrowing of interpedicular distances, fibula longer than tibia, square iliae, and short femoral necks. Sequence analysis of FGFR3 exons 9, 10, 13, and 15 is recommended for a diagnosis of HCP (<xref ref-type="bibr" rid="ref6">6</xref>). Sequence analysis of exon 10 which allows detection of the G380R mutation associated with ACP is added to molecular diagnostic test because of the clinical overlap between mild ACP and severe HCP (<xref ref-type="bibr" rid="ref6">6</xref>). 1620C&gt;A and 1620C&gt;G mutations which lead to Asn540Lys aminoacid substitution are detected in approximately 50-70% of affected individuals (<xref ref-type="bibr" rid="ref4">4</xref>). Codon 540 in exon 13 is a major hotspot (<xref ref-type="bibr" rid="ref7">7</xref>). The other mutations of this gene account for fewer than 2% of HCP patients (<xref ref-type="bibr" rid="ref8">8</xref>). However, familial cases who were not linked to FGFR3 have been reported that support a genetically heterogeneous condition (<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref>). FGFR3 is a negative regulator of bone growth and all mutations of FGFR3 are gain-of-function mutations that lead to skeletal dysplasias (<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref>). The phenotype of HCP is similar, but milder compared to ACP. Therefore, HCP is rarely recognized before the age of 3 years (<xref ref-type="bibr" rid="ref6">6</xref>). In our patient, a diagnosis of HCP was suspected at age of 4 8/12 years. Skeletal features are reported to be more severe in HCP patients with Asn540Lys mutations than in HCP patients without the FGFR3 Asn540Lys mutation (<xref ref-type="bibr" rid="ref6">6</xref>).</p>
      <p>N540K mutations in the FGFR3 cause the most severe forms of sporadic HCP (<xref ref-type="bibr" rid="ref10">10</xref>). In patients with N540K mutations, adult height ranges from 138 cm to 155 cm in men and from 128 cm to 145 cm in women (<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref14">14</xref>). The use of recombinant growth hormone (rGH) therapy for HCP has been evaluated by several centers in trials (<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref18">18</xref>). In most of these trials, a statistically significant increase in predicted growth rate was reported. However, there was also a concern that rGH might aggravate body disproportion, a question that remains under debate (<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref17">17</xref>). Thus, rGH therapy for HCP is still considered experimental and controversial (<xref ref-type="bibr" rid="ref6">6</xref>). The only possible alternative to rGH treatment is a limb-lengthening procedure. Although the complication rate of this procedure was initially high, outcomes have steadily improved, and significant increases in overall height up to 7-12 cm have been reported (<xref ref-type="bibr" rid="ref19">19</xref>). However, this procedure is invasive and entails disability and discomfort (<xref ref-type="bibr" rid="ref6">6</xref>). We decided that our patient would receive rGH therapy.</p>
      <p>It has been estimated that 10 to 20% of cases of HCP had mild mental handicap (<xref ref-type="bibr" rid="ref20">20</xref>). Recently, mental retardation has been reported in a HCP patient with Asn540Lys mutation in FGFR3 gene (<xref ref-type="bibr" rid="ref21">21</xref>). The patient presented in this report is another example of mental retardation occurring as a clinical consequence of Asn540Lys mutation.</p>
      <p>In summary, mutation screening is appropriate when the clinical and radiological features of a patient reveal findings suggestive of a skeletal dysplasia. The presence of FGFR3 mutations dominates the clinical picture and its identification is important not only for genetic counseling and recurrence risk but also to provide information on perinatal lethality, severity of the dysplasia and prognosis. A coordinated collaboration between gynecologists, pediatricians and geneticists is needed for the evaluation of such patients. </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Spranger</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Hypochondroplasia: clinical and radiological aspects in 39 cases</article-title>
          <source>Radiology</source>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Matsui</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yasui</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tsumaki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kawabata</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ochi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Genotype phenotype correlation in achondroplasia and hypochondroplasia</article-title>
          <source>J Bone Joint Surg Br</source>
          <year>1998</year>
          <volume>80</volume>
          <fpage>1052</fpage>
          <lpage>1056</lpage>
          <pub-id pub-id-type="pmid">9853502</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Keegan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rooke</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hayman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Spurr</surname>
              <given-names>NK</given-names>
            </name>
          </person-group>
          <article-title>The fibroblast growth factor receptor 3 gene (FGFR3) is assigned to human chromosome 4</article-title>
          <source>Cytogenet Cell Genet</source>
          <year>1993</year>
          <volume>62</volume>
          <fpage>172</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="pmid">8428519</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Bellus</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Spector</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Speiser</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Garber</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Bryke</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Israel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rosengren</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Donoghue</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Francomano</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Distinct missense mutation of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype</article-title>
          <source>Am J Hum Genet</source>
          <year>2000</year>
          <volume>67</volume>
          <fpage>1411</fpage>
          <lpage>1421</lpage>
          <pub-id pub-id-type="pmid">11055896</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Mortier</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nuytinck</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Craen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Renard</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Leroy</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Paepe</surname>
              <given-names>A</given-names>
              <suffix>de</suffix>
            </name>
          </person-group>
          <article-title>Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblastgrowth factor receptor 3 gene</article-title>
          <source>J Med Genet</source>
          <year>2000</year>
          <volume>37</volume>
          <fpage>220</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="pmid">10777366</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="book" publication-format="web">
          <publisher-name>University of Washington, Seattle</publisher-name>
          <source>Francomano CA. Hypochondroplasia. GeneReviews Source:</source>
          <year>2005</year>
          <comment>[Internet]</comment>
          <comment>
            <uri xlink:type="simple" xlink:href="https://www.washington.edu/">https://www.washington.edu/</uri>
          </comment>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Bellus</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>McIntosh</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aylsworth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kaitila</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Francomano</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>1996</year>
          <volume>785</volume>
          <fpage>182</fpage>
          <lpage>187</lpage>
          <pub-id pub-id-type="pmid">8702125</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Castro-Feijoo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Loidi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vidal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Parajes</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Roson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Alvarez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cabanas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Barreiro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Alonso</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dominguez</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pombo</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Hypochondroplasia and Acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?</article-title>
          <source>Eur J Endocrinol</source>
          <year>2008</year>
          <volume>159</volume>
          <fpage>243</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="pmid">18583390</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Vajo</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Francomano</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Wilkin</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasia, Muenke craniosynostosis and Crouzon syndrome with acanthosis nigricans</article-title>
          <source>Endocr Rev</source>
          <year>2000</year>
          <volume>21</volume>
          <fpage>23</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">10696568</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Rousseau</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bonaventure</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Legeai-Mallet</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Weissenbach</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Maroteaux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Munnich</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Le Merrer</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Clinical and genetic heterogeneity of hypochondroplasia</article-title>
          <source>J Med Genet</source>
          <year>1996</year>
          <volume>33</volume>
          <fpage>749</fpage>
          <lpage>752</lpage>
          <pub-id pub-id-type="pmid">8880574</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Deng</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wynshaw-Boris</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leder</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Fibroblast growth factor receptor 3 is a negative regulator of bone growth</article-title>
          <source>Cell</source>
          <year>1996</year>
          <volume>84</volume>
          <fpage>911</fpage>
          <lpage>921</lpage>
          <pub-id pub-id-type="pmid">8601314</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Tavormina</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Bellus</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Bamshad</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Fraley</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>McIntosh</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jabs</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Wilcox</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Wasmuth</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Donoghue</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Francomano</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene</article-title>
          <source>Am J Hum Genet</source>
          <year>1999</year>
          <volume>64</volume>
          <fpage>722</fpage>
          <lpage>731</lpage>
          <pub-id pub-id-type="pmid">10053006</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Maroteaux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Falzon</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Hypochondroplasia: review of 80 cases</article-title>
          <source>Arch Fr Pediatr</source>
          <year>1988</year>
          <volume>45</volume>
          <fpage>105</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="pmid">3389972</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Bridges</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Hindmarsh</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Brook</surname>
              <given-names>CG</given-names>
            </name>
          </person-group>
          <article-title>Growth of children with hypochondroplasia treated with growth hormone for up to three years</article-title>
          <source>Horm Res</source>
          <year>1991</year>
          <volume>36</volume>
          <fpage>56</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">1806487</pub-id>
        </element-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Burren</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Werther</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
          <article-title>Skeletal dysplasias: response to growth hormone therapy</article-title>
          <source>J Pediatr Endocrinol Metab</source>
          <year>1996</year>
          <volume>9</volume>
          <fpage>31</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">8887131</pub-id>
        </element-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Ramaswami</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Hindmarsh</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Brook</surname>
              <given-names>CGD</given-names>
            </name>
          </person-group>
          <article-title>Growth hormone therapy in hypochondroplasia</article-title>
          <source>Acta Paediatr</source>
          <year>1999</year>
          <volume>88</volume>
          <fpage>116</fpage>
          <lpage>117</lpage>
        </element-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Hagenas</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hertel</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Skeletal dysplasia, growth hormone treatment and body proportion: comparison with other syndromic and non-syndromic short children</article-title>
          <source>Horm Res</source>
          <year>2003</year>
          <volume>60</volume>
          <fpage>65</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">14671400</pub-id>
        </element-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Rothenbuhler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Linglart</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Piquard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bougneres</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>A pilot study of discontinuous, insulin-like growth factor 1-dosing growth hormone treatment in young children with FGFR3 N540K-mutated hypochondroplasia</article-title>
          <source>J Pediatr</source>
          <year>2012</year>
          <volume>160</volume>
          <fpage>849</fpage>
          <lpage>853</lpage>
          <pub-id pub-id-type="pmid">22137367</pub-id>
        </element-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Yasui</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kawabata</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kojimoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shimomura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ochi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Lengthening of the lower limbs in patients with achondroplasia and hypochondroplasia</article-title>
          <source>Clin Orthop Relat Res</source>
          <year>1997</year>
          <volume>344</volume>
          <fpage>298</fpage>
          <lpage>306</lpage>
          <pub-id pub-id-type="pmid">9372781</pub-id>
        </element-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Wynne-Davies</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Patton</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>The frequency of mental retardation in hypochondroplasia</article-title>
          <source>J Med Genet</source>
          <year>1991</year>
          <volume>28</volume>
          <fpage>644</fpage>
          <lpage>644</lpage>
          <pub-id pub-id-type="pmid">1956068</pub-id>
        </element-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez Delgado</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Guerrero Fernandez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gracia Bouthelier</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Hypochondroplasia and mental retardation</article-title>
          <source>An Pediatr (Barc)</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>629</fpage>
          <lpage>632</lpage>
          <pub-id pub-id-type="pmid">18559210</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>patient at 5 demonstrating short stature</title>
      </caption>
      <graphic xlink:href="JCRPE-4-220-g1"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
